Business Description
AI/ML Innovations Inc
NAICS : 923120
SIC : 8691
ISIN : CA3181471051
Description
AI/ML Innovations Inc has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence and machine learning, with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. The company has strategic partnerships with Health Gauge, Tech2Health and other planned accretive investments.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.51 | |||||
Equity-to-Asset | 0.34 | |||||
Debt-to-Equity | 0.19 | |||||
Debt-to-EBITDA | -0.11 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -21.66 | |||||
Beneish M-Score | -0.14 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -91.9 | |||||
3-Year EPS without NRI Growth Rate | -82.3 | |||||
3-Year FCF Growth Rate | -362.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 80.76 | |||||
9-Day RSI | 62.27 | |||||
14-Day RSI | 54.14 | |||||
6-1 Month Momentum % | -16.68 | |||||
12-1 Month Momentum % | -66.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.46 | |||||
Quick Ratio | 0.46 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 4.75 | |||||
Days Sales Outstanding | 53.46 | |||||
Days Payable | 492.55 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -62.8 | |||||
Shareholder Yield % | -46.56 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.66 | |||||
Operating Margin % | -222.33 | |||||
Net Margin % | -254.77 | |||||
FCF Margin % | -257.18 | |||||
ROE % | -215.41 | |||||
ROA % | -67.16 | |||||
ROIC % | -69.88 | |||||
ROC (Joel Greenblatt) % | -4458.12 | |||||
ROCE % | -308.46 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.11 | |||||
PB Ratio | 5.5 | |||||
Price-to-Tangible-Book | 4.03 | |||||
EV-to-EBIT | -3.27 | |||||
EV-to-EBITDA | -3.35 | |||||
EV-to-Revenue | 8.14 | |||||
EV-to-FCF | -3.17 | |||||
Earnings Yield (Greenblatt) % | -30.58 | |||||
FCF Yield % | -29.07 |